Hisamitsu Pharmaceutical: Announcements of individual stocks: Announcement of results for the domestic Phase 2 clinical trial of HP-6050 (transdermal sedative).
Hisamitsu Pharmaceutical: [Postponed] Corporate Governance Report
Hisamitsu Pharmaceutical: Kusuri Pharmaceutical has chosen Mr. Mukai to be the image character for their new TV commercial for Escap. It will start airing nationwide from Saturday, June 8th, 2024 with a focus on morning self-care in the cell.
Hisamitsu Pharmaceutical: Report on the Status of Purchases of Treasury Stock by the Company (Based on Article 24-6, Paragraph 1 of the Law)
Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Hisamitsu Pharmaceutical: Notice of price revisions
Hisamitsu Pharmaceutical: Hisamitsu Pharmaceutical's new “Salonpas” TV-commercial features Alice Hirose as the new image character! “Immediate Attachment Course” version will be on air nationwide from 2024/5/31 (Friday)
Hisamitsu Pharmaceutical: New TV commercial featuring primary palmar hyperhidrosis disease awareness characters will go on air nationwide from 2024/6/1 (Sat)
Hisamitsu Pharmaceutical: Corporate Governance Report 2024/05/24
Hisamitsu Pharmaceutical: Confirmation letter
Hisamitsu Pharmaceutical: Internal Control Report - 122nd Term (2023/03/01 - 2024/02/29)
Hisamitsu Pharmaceutical: Financial Report - 122nd Term (2023/03/01 - 2024/02/29)
Hisamitsu Pharmaceutical: Extraordinary Report
Hisamitsu Pharmaceutical: Notice regarding the results and termination of treasury stock acquisition through off-the-counter share purchase transactions (ToSTnet-3)
Hisamitsu Pharmaceutical: Notice Concerning Repurchase of Treasury Shares and Purchase of Treasury Shares through Off-Auction Share Repurchase Transactions (ToSTNet-3)
Hisamitsu Pharmaceutical: Executive personnel
Hisamitsu Pharmaceutical: Salonpas certified as the world's No. 1 sales share brand for 8 consecutive years
Hisamitsu Pharmaceutical: Notice of obtaining “DX certification” as determined by the Ministry of Economy, Trade and Industry
Hisamitsu Pharmaceutical: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Hisamitsu Pharmaceutical: Independent Officer Notification Form
No Data